| Health Care Technology Industry | Healthcare Sector | Dr. Ina Laura Perkins CEO | XFRA Exchange | SE0023286836 ISIN |
| Sweden Country | 15 Employees | - Last Dividend | 21 Nov 2024 Last Split | - IPO Date |
Scandinavian Real Heart AB (Publ) is a pioneering medical technology company based in Västerås, Sweden, primarily focused on the innovation and development of artificial heart solutions. Founded in 2007, their mission is to provide advanced treatments for patients suffering from severe heart failure. The company is at the forefront of creating artificial heart devices, leveraging cutting-edge technology to extend and improve the quality of life for individuals with heart conditions that are beyond conventional treatment methods.
Realheart TAH
Realheart TAH, or Total Artificial Heart, represents Scandinavian Real Heart AB's flagship development. This revolutionary product is designed for patients experiencing advanced-stage heart failure. It mimics the human heart's functionality, offering a promising solution for those in critical need of heart transplantation but facing the dire shortage of donor organs. It serves as a bridge to transplantation or as a long-term solution for those ineligible for a heart transplant.
RealVAD
The RealVAD system is a ventricular assist device focusing on supporting the left ventricle of the heart. This product is particularly beneficial for patients with left-sided heart failure, enhancing their heart's pumping capacity. RealVAD operates with a pulsating mechanism which closely resembles the natural heartbeat, thereby providing a more physiological approach to heart assistance.
PulsePump
PulsePump is an innovative device engineered for use with heart and lung machines during surgeries requiring cardiopulmonary bypass. It is designed to generate a pulsating flow that mimics the natural pulsation of blood through the human body. This feature is significant as it aims to reduce complications and improve outcomes for patients undergoing open-heart surgery by maintaining a more natural blood flow.
Sternal Prosthesis
Aiming to address the challenges associated with healing after open-chest surgery, Scandinavian Real Heart AB has developed a Sternal Prosthesis. This product is crucial for patients who have undergone surgeries that involve opening the sternum, as it provides a reliable method to secure and stabilize the chest wall during the critical healing period. This innovation not only improves patient recovery times but also significantly reduces the risk of post-operative complications associated with sternotomy procedures.